YU15175A - Process for producing 7-(oxoalkyl)-1,3-dialkylxanthine - Google Patents

Process for producing 7-(oxoalkyl)-1,3-dialkylxanthine

Info

Publication number
YU15175A
YU15175A YU00151/75A YU15175A YU15175A YU 15175 A YU15175 A YU 15175A YU 00151/75 A YU00151/75 A YU 00151/75A YU 15175 A YU15175 A YU 15175A YU 15175 A YU15175 A YU 15175A
Authority
YU
Yugoslavia
Prior art keywords
dialkylxanthine
oxoalkyl
producing
Prior art date
Application number
YU00151/75A
Other languages
English (en)
Inventor
G Brenner
J Goering
Khan E Ali
O Rohte
M Tauscher
Original Assignee
Wuelfing Johann A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2402908A external-priority patent/DE2402908C2/de
Application filed by Wuelfing Johann A filed Critical Wuelfing Johann A
Publication of YU15175A publication Critical patent/YU15175A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU00151/75A 1974-01-22 1975-01-22 Process for producing 7-(oxoalkyl)-1,3-dialkylxanthine YU15175A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2402908A DE2402908C2 (de) 1974-01-22 1974-01-22 7-(3-Oxobutyl)-1,3-di-(n-butyl)-xanthin und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
YU15175A true YU15175A (en) 1982-06-30

Family

ID=5905372

Family Applications (1)

Application Number Title Priority Date Filing Date
YU00151/75A YU15175A (en) 1974-01-22 1975-01-22 Process for producing 7-(oxoalkyl)-1,3-dialkylxanthine

Country Status (13)

Country Link
US (2) US4242345A (en:Method)
JP (1) JPS5912677B2 (en:Method)
AR (1) AR207462A1 (en:Method)
AT (1) AT338286B (en:Method)
BE (1) BE824665A (en:Method)
CA (1) CA1068693A (en:Method)
CH (1) CH608236A5 (en:Method)
FI (2) FI801875A7 (en:Method)
FR (1) FR2258183B1 (en:Method)
GB (1) GB1441562A (en:Method)
HU (1) HU169012B (en:Method)
NL (1) NL184330C (en:Method)
YU (1) YU15175A (en:Method)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2507554A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2507555A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
EP0005015B1 (en) * 1978-04-22 1986-10-29 BEECHAM - WUELFING GmbH & Co. KG Use of a xanthine derivate in the manufacture of a medicament
IL59665A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
EP0157098A1 (en) * 1980-06-21 1985-10-09 Beecham Wuelfing GmbH & Co KG Xanthine derivatives, pharmaceuticals compositions containing them and a process for their preparation
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5096906A (en) * 1986-12-31 1992-03-17 University Of Virginia Alumni Patents Foundation Method of inhibiting the activity of leukocyte derived cytokines
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
ATE138266T1 (de) * 1990-11-07 1996-06-15 Hoechst Roussel Pharma Verwendung von xanthinen zur herstellung von arzneimitteln zur hemmung der vermehrung menschlicher retroviren
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
MX9203323A (es) * 1991-07-11 1994-07-29 Hoechst Ag El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales.
TW288977B (en:Method) * 1992-02-22 1996-10-21 Hoechst Ag
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US6448235B1 (en) 1994-07-11 2002-09-10 University Of Virginia Patent Foundation Method for treating restenosis with A2A adenosine receptor agonists
US6514949B1 (en) 1994-07-11 2003-02-04 University Of Virginia Patent Foundation Method compositions for treating the inflammatory response
US6232297B1 (en) * 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US7427606B2 (en) * 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
US7378400B2 (en) * 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
US6322771B1 (en) 1999-06-18 2001-11-27 University Of Virginia Patent Foundation Induction of pharmacological stress with adenosine receptor agonists
US6670334B2 (en) 2001-01-05 2003-12-30 University Of Virginia Patent Foundation Method and compositions for treating the inflammatory response
WO2003029264A2 (en) * 2001-10-01 2003-04-10 University Of Virginia Patent Foundation 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
US7442687B2 (en) * 2004-08-02 2008-10-28 The University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having A2A agonist activity
CA2576826C (en) * 2004-08-02 2014-09-30 University Of Virginia Patent Foundation 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
US7576069B2 (en) * 2004-08-02 2009-08-18 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having A2A agonist activity
US8178509B2 (en) * 2006-02-10 2012-05-15 University Of Virginia Patent Foundation Method to treat sickle cell disease
US8188063B2 (en) 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
US8058259B2 (en) 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756229A (en) * 1956-07-24 Xanthine derivatives
CA557342A (en) 1958-05-13 Doebel Karl Process for the manufacture of novel xanthine derivatives
US2761863A (en) * 1956-09-04 Lower-alkyl
FR4791E (fr) 1900-06-29 1905-10-16 Eugene Fournier Lampe à pétrole perfectionnée pour chauffage intensif dite: "la naphteuse"
DE926788C (de) 1952-11-07 1955-04-25 Geigy Ag J R Verfahren zur Herstellung von 1, 3-dialkylierten 7-Oxyalkyl-xanthinabkoemmlingen
GB759174A (en) * 1952-11-07 1956-10-17 Geigy Ag J R Improvements in diuretic acting xanthine derivatives
GB759981A (en) * 1953-09-09 1956-10-24 Roche Products Ltd Process for the manufacture of xanthine derivatives
CH325292A (de) 1953-10-21 1957-10-31 Geigy Ag J R Verfahren zur Herstellung von 7-Oxyalkyl-xanthinderivaten
US3737433A (en) * 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
DE2234202A1 (de) 1972-07-12 1974-01-24 Albert Ag Chem Werke Verfahren zur herstellung von oxoalkylxanthinen
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2457666A1 (de) * 1974-12-06 1976-06-10 Hoechst Ag Arzneimittel, verfahren zur herstellung von dafuer geeigneten wirkstoffen und diese oxoalkyl-dialkyl-xanthine
JPS5233120A (en) * 1975-09-10 1977-03-14 Nisshin Steel Co Ltd Double coiled automobile steel pipe covered with heat flexible plastic resin

Also Published As

Publication number Publication date
US4242345A (en) 1980-12-30
HU169012B (en:Method) 1976-08-28
ATA929674A (de) 1976-12-15
NL184330B (nl) 1989-01-16
JPS50101386A (en:Method) 1975-08-11
FR2258183B1 (en:Method) 1978-07-28
GB1441562A (en) 1976-07-07
FI801875A7 (fi) 1981-01-01
FI59596C (fi) 1981-09-10
US4291037A (en) 1981-09-22
AT338286B (de) 1977-08-10
AR207462A1 (es) 1976-10-08
CH608236A5 (en:Method) 1978-12-29
FI750122A7 (en:Method) 1975-07-23
NL184330C (nl) 1989-06-16
NL7414887A (nl) 1975-07-24
JPS5912677B2 (ja) 1984-03-24
FI59596B (fi) 1981-05-29
BE824665A (fr) 1975-05-15
FR2258183A1 (en:Method) 1975-08-18
CA1068693A (en) 1979-12-25

Similar Documents

Publication Publication Date Title
YU15175A (en) Process for producing 7-(oxoalkyl)-1,3-dialkylxanthine
HU174077B (hu) Sposob poluchenija proizvodnykh dekapeptidamidakh
YU120082A (en) Process for obtaining substituted purines
HU173541B (hu) Sposob poluchenija 21-fenilsul'fonil-pregna-4,17-skobka zakryta-,20-tien-3-onov
HU172697B (hu) Sposob poluchenija proizvodnykh tieno-skobka-2,3-c-skobka zakryta-piridina
HU173052B (hu) Sposob poluchenija proizvodnykh tienil-karbamida
HU172039B (hu) Sposob poluchenija proizvodnykh 2-fenil-indola
HU172103B (hu) Sposob poluchenija proizvodnykh 2-skobka-zamehhennykh-skobka zakryta-3-cianamino-3-skobka-zamehhennykh amino-skobka zakryta-propionitrilov
HU172906B (hu) Sposob poluchenija proizvodnykh alkil-amino-glikopiranozida
YU40266B (en) Process for producing thienothiazepine derivatives
HU174005B (hu) Sposob poluchenija proizvodnykh analogov prostaglandina
HU171512B (hu) Sposob polucsenija proizvodnykh nikotinamid-adenin-dinukleotidov
HU173985B (hu) Sposob poluchenija proizvodnykh d-8al'fa,8beta-dvezamehhjonnogo-6-metil-ehrgolina i -ehrgolena
HU173609B (hu) Sposob poluchenija novykh proizvodnykh salicilanilida
YU39004B (en) Process for preparing new xanthine derivatives
CH611289A5 (en) Process for preparing 7-substituted 8-aminomethylisoflavones
HU171575B (hu) Sposob poluchenija s-tetrazolo-kvadratnaja skobka-3,4-b-kvadratnaja skobka zakryta-benzotiazolov
HU172146B (hu) Sposob poluchenija proizvodnykh cinnolina
HU173395B (hu) Sposob poluchenija proizvodnykh estren-3,17-diona
YU165781A (en) Process for producing penzopyran derivatives
HU171165B (hu) Sposob poluchenija proizvodnykh oktagidro-indolo-skobka-2,3-a-skobka zakryta-kinolizina
HU173528B (hu) Sposob poluchenija steroid-skobka-16-al'fa,17-b-skobka zakryta-naftalinov
YU326975A (en) Process for producing new dianhydro-hexyte derivatives
HU172063B (hu) Sposob poluchenija priozvodnykh n-skobka-5-tetrazolil-skobka zakryta-1-okso-6-alkoksi-1h-pirimido-skobka-1,2-a-skobka zakryta-kinolin-2-karboksamidov
HU174067B (hu) Sposob poluchenija zamehhennykh proizvodnykh 2h-piran-2,6-diona